REGENERON PHARMACEUTICALS, INC. Available-for-sale Securities, Gross Realized Losses
REGENERON PHARMACEUTICALS, INC. (REGN) reported Available-for-sale Securities, Gross Realized Losses of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-09.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses · last filed 2017-02-09
- REGENERON PHARMACEUTICALS, INC. available-for-sale securities, gross realized losses for the quarter ending 2013-12-31 was $0.00.
- REGENERON PHARMACEUTICALS, INC. available-for-sale securities, gross realized losses for the quarter ending 2013-09-30 was $0.00.
- REGENERON PHARMACEUTICALS, INC. available-for-sale securities, gross realized losses for the quarter ending 2013-06-30 was $0.00.
- REGENERON PHARMACEUTICALS, INC. available-for-sale securities, gross realized losses for fiscal 2014 was $0.00.
- REGENERON PHARMACEUTICALS, INC. available-for-sale securities, gross realized losses for fiscal 2013 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Losses 3 month | Available-for-sale Securities, Gross Realized Losses 6 month | Available-for-sale Securities, Gross Realized Losses 9 month | Available-for-sale Securities, Gross Realized Losses 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2017-02-09 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $0.00 derived: sum of 2 quarters · filed 2016-02-11 | $0.00 derived: sum of 3 quarters · filed 2016-02-11 | $0.00 10-K · filed 2016-02-11 |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-04 | $0.00 derived: sum of 2 quarters · filed 2014-11-04 | $0.00 10-Q · filed 2014-11-04 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-05 | $0.00 10-Q · filed 2014-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |